EA200401082A1 - Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат - Google Patents

Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат

Info

Publication number
EA200401082A1
EA200401082A1 EA200401082A EA200401082A EA200401082A1 EA 200401082 A1 EA200401082 A1 EA 200401082A1 EA 200401082 A EA200401082 A EA 200401082A EA 200401082 A EA200401082 A EA 200401082A EA 200401082 A1 EA200401082 A1 EA 200401082A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzoindoline
contain
production
pharmaceutical compositions
new compounds
Prior art date
Application number
EA200401082A
Other languages
English (en)
Other versions
EA007231B1 (ru
Inventor
Жильбер Лавьелль
Оливье Мюлле
Марк Миллан
Ален Гобер
Бенжамен Де-Кара
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200401082A1 publication Critical patent/EA200401082A1/ru
Publication of EA007231B1 publication Critical patent/EA007231B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Соединения формулы (I)в которой R, R, Rи Rявляются такими, как определено в описании, их аддитивные соли с фармацевтически приемлемой кислотой или основанием. Лекарственные средства.
EA200401082A 2003-09-16 2004-09-15 Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат EA007231B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0310828A FR2859723B1 (fr) 2003-09-16 2003-09-16 Nouveaux derives de benzoindoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
EA200401082A1 true EA200401082A1 (ru) 2005-04-28
EA007231B1 EA007231B1 (ru) 2006-08-25

Family

ID=34178903

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401082A EA007231B1 (ru) 2003-09-16 2004-09-15 Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат

Country Status (17)

Country Link
US (1) US6998403B2 (ru)
EP (1) EP1516871A1 (ru)
JP (1) JP2005097303A (ru)
KR (1) KR20050027967A (ru)
CN (1) CN1616425A (ru)
AR (1) AR045749A1 (ru)
AU (1) AU2004212578A1 (ru)
BR (1) BRPI0404006A (ru)
CA (1) CA2480218A1 (ru)
EA (1) EA007231B1 (ru)
FR (1) FR2859723B1 (ru)
MA (1) MA27109A1 (ru)
MX (1) MXPA04008880A (ru)
NO (1) NO20043880L (ru)
NZ (1) NZ535332A (ru)
SG (1) SG110170A1 (ru)
ZA (1) ZA200407444B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009005668A (es) 2006-12-07 2009-06-08 Grace Gmbh & Co Kg Agente para deslustrar.
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
JP6472419B2 (ja) 2015-09-30 2019-02-20 富士フイルム株式会社 芳香族化合物の製造方法
CN105367513A (zh) * 2015-11-11 2016-03-02 北京万全德众医药生物技术有限公司 普拉克索衍生物的结构及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810979B1 (fr) * 2000-06-29 2002-08-23 Adir Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MA27109A1 (fr) 2004-12-20
US6998403B2 (en) 2006-02-14
BRPI0404006A (pt) 2005-06-21
FR2859723B1 (fr) 2005-10-21
ZA200407444B (en) 2005-06-30
KR20050027967A (ko) 2005-03-21
NO20043880L (no) 2005-03-17
US20050059675A1 (en) 2005-03-17
AU2004212578A1 (en) 2005-04-07
FR2859723A1 (fr) 2005-03-18
EP1516871A1 (fr) 2005-03-23
CN1616425A (zh) 2005-05-18
EA007231B1 (ru) 2006-08-25
MXPA04008880A (es) 2007-07-18
AR045749A1 (es) 2005-11-09
SG110170A1 (en) 2005-04-28
JP2005097303A (ja) 2005-04-14
CA2480218A1 (fr) 2005-03-16
NZ535332A (en) 2006-02-24

Similar Documents

Publication Publication Date Title
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
SE0401971D0 (sv) Piperidne derivatives
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
SE0202463D0 (sv) Novel compounds
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
SE0302811D0 (sv) Novel compounds
NO20054787L (no) Indenderivater som farmasotiske midler
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
EA200800502A1 (ru) Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения
EA200500690A1 (ru) Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
SE0401970D0 (sv) Novel compounds
EA200800393A1 (ru) Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
EA200601845A1 (ru) НОВЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
AR057885A1 (es) Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas.
SE0203303D0 (sv) Novel Compounds

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU